Pharmaceutical Kalbe Farma (KLBF) plans to expand to Middle East, mainly Dubai. It will seek local partner in Dubai and to open representative office. Now KLBF is observing the market potential in Dubai. It plans to develop its export-oriented product, Hydro Coco. Export product now contributes 5% of total sales and KLBF wants to boost export contribution to 10%. KLBF’s main products for export are such as Mixagrip (in Myanmar), Diabetasol (in Philippines), and Procold (in southeast Asia). For 2017, KLBF targets 8-10% growth in revenues and net profit. In 2016, it booked net profit of Rp2.3 trillion on revenues of Rp19.37 trillion. The Company targets to launch 12-15 new products this year. It allocates capital expenditure (capex) of Rp1-1.2 trillion for this year. KLBF also plans to build 4 new factories this year.